Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report released on Friday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE AMPE opened at $0.00 on Friday. The stock has a market capitalization of $2,951.00, a PE ratio of 0.00 and a beta of 3.71. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.47. The stock has a 50 day moving average price of $0.02 and a 200 day moving average price of $0.02.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.